Template:Nucleic acid inhibitors: Difference between revisions
Content deleted Content added
No edit summary |
Innerstream (talk | contribs) No edit summary |
||
| (38 intermediate revisions by 30 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox |
{{Navbox |
||
| name |
| name = Nucleic acid inhibitors |
||
| title |
| title = [[Antibiotics|Antibacterials]] that [[nucleic acid inhibitor|inhibit nucleic acid]] ([[ATC code J01#J01E|J01E]], [[ATC code J01#J01M|J01M]]) |
||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
|||
| listclass = hlist |
|||
| listclass = hlist |
|||
| group1 = [[Antifolate]]s<br/>(inhibit bacterial<br/>[[purine metabolism|purine metabolism]],<br/>thereby inhibiting<br/>DNA and RNA<br/>synthesis) |
|||
| groupstyle = background:PowderBlue; |
|||
| list1 = {{Navbox|child |
|||
| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitor]] |
|||
| group1 = [[Antifolate]]s<br />(inhibits<br/>[[purine metabolism]],<br />thereby inhibiting<br/> DNA and RNA synthesis) |
|||
| list1 = |
|||
| list1 = {{Navbox|child |
|||
* [[2,4-Diaminopyrimidine]] |
|||
| groupstyle = background:PowderBlue; |
|||
| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitor]] |
|||
| list1 = |
|||
* ''[[2,4-Diaminopyrimidine]]'' |
|||
** [[Trimethoprim]]<sup>#</sup> |
|||
** [[Brodimoprim]] |
** [[Brodimoprim]] |
||
** [[Iclaprim]]<sup>†</sup> |
|||
** [[Ormetoprim]] |
|||
** [[Pyrimethamine]]<sup>#</sup> |
|||
** [[Tetroxoprim]] |
** [[Tetroxoprim]] |
||
** [[ |
** [[Trimethoprim]]<sup>#</sup> |
||
| group2 = [[Sulfonamide (medicine)|Sulfonamides]]<br />([[Dihydropteroate synthetase inhibitor|DHPS inhibitor]]) |
|||
| list2 = {{Navbox|child |
|||
| groupstyle = background-color: PowderBlue |
|||
| group1 = [[ |
| group1 = [[Sulfonamide (medicine)#Short-acting|Short-acting]] |
||
| list1 |
| list1 = |
||
* [[Sulfisomidine|Sulfaisodimidine]] |
* [[Sulfisomidine|Sulfaisodimidine]] |
||
* [[Sulfamethizole]] |
* [[Sulfamethizole]] |
||
* [[Sulfadimidine]] |
* [[Sulfadimidine]] |
||
* [[Sulfapyridine]] |
* [[Sulfapyridine]] ([[Sulfasalazine]]) |
||
* [[Sulfafurazole]] |
* [[Sulfafurazole]] ([[Acetyl sulfisoxazole]]) |
||
* [[Sulfanilamide]] |
* [[Sulfanilamide]] |
||
** [[Prontosil]] |
** [[Prontosil]] |
||
* [[Sulfathiazole]] |
* [[Sulfathiazole]] ([[Phthalylsulfathiazole]], [[Succinylsulfathiazole]]) |
||
* [[Sulfathiourea]] |
* [[Sulfathiourea]] |
||
| group2 = [[ |
| group2 = [[Sulfonamide (medicine)#Intermediate-acting|Intermediate-acting]] |
||
| list2 |
| list2 = |
||
* [[Sulfamethoxazole]] |
* [[Sulfamethoxazole]] |
||
* [[Sulfadiazine]]<sup>#</sup> |
* [[Sulfadiazine]]<sup>#</sup> |
||
* [[Sulfamoxole]] |
* [[Sulfamoxole]] |
||
| group3 = [[ |
| group3 = [[Sulfonamide (medicine)#Long-acting|Long-acting]] |
||
| list3 |
| list3 = |
||
* [[Sulfadimethoxine]] |
* [[Sulfadimethoxine]] |
||
* [[Sulfadoxine]] |
* [[Sulfadoxine]] |
||
| Line 53: | Line 52: | ||
* [[Sulfamazone]] |
* [[Sulfamazone]] |
||
| group4 = Other/ungrouped |
|||
}} |
|||
| list4 = |
|||
* [[Mafenide]] |
|||
* [[Sulfacetamide]] |
|||
* [[Sulfaclozine]] |
|||
* [[Sulfadicramide]] |
|||
* [[Sulfaguanidine]] |
|||
* [[Sulfametrole]] |
|||
* [[Sulfanitran]] |
|||
}} |
|||
| group5 = Other/ungrouped |
|||
| list5 = |
|||
* ''[[sulfanilamide]]'' |
|||
** [[Sulfacetamide]] |
|||
** [[Sulfametrole]] |
|||
| |
| group3 = Combinations |
||
| list3 = |
|||
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
||
* [[Sulfadimethoxine#with ormetoprim|Ormetoprim/sulfadimethoxine]] |
|||
* [[Pyrimethamine/dapsone]] |
|||
* [[Pyrimethamine/sulfadoxine]] |
|||
}} |
|||
| group2 = [[Topoisomerase inhibitor|Topoisomerase<br/> inhibitors]]/<br />[[quinolones]]/<br />(inhibits<br/>[[DNA replication]]) |
|||
| list2 = {{Navbox|child |
|||
| groupstyle = background:PowderBlue; |
|||
| group4 = Other DHPS inhibitors |
|||
| group1 = [[Fluoroquinolone#1st_generation|1st g.]] |
|||
| list4 = |
|||
* [[Acediasulfone]] |
|||
* [[Dapsone]] |
|||
* [[Solasulfone]] |
|||
* [[Sulfoxone]] |
|||
}} |
|||
| group2 = [[Quinolone antibiotic|Quinolone]]s<br/>(inhibit bacterial<br/>[[Topoisomerase inhibitor|topoisomerase]]<br/>and/or [[DNA gyrase|DNA gyrase]],<br/>thereby inhibiting<br/>[[DNA replication]]) |
|||
| list2 = {{Navbox|child |
|||
| group1 = [[Quinolone antibiotic#First generation|1st generation]] |
|||
| list1 = |
|||
* [[Cinoxacin]]<sup>‡</sup> |
* [[Cinoxacin]]<sup>‡</sup> |
||
* [[Flumequine]] |
* [[Flumequine]]<sup>‡</sup> |
||
* [[Nalidixic acid]] |
* [[Nalidixic acid]]<sup>‡</sup> |
||
* [[Oxolinic acid]] |
* [[Oxolinic acid]]<sup>‡</sup> |
||
* [[Pipemidic acid]] |
* [[Pipemidic acid]]<sup>‡</sup> |
||
* [[Piromidic acid]] |
* [[Piromidic acid]]<sup>‡</sup> |
||
* [[Rosoxacin]] |
* [[Rosoxacin]]<sup>‡</sup> |
||
| group2 = [[Quinolone antibiotic|Fluoroquinolones]] |
|||
| group2 = [[Fluoroquinolone|Fluoro-<br />quinolone]]s |
|||
| list2 = {{Navbox|child |
|||
| groupstyle = background-color: PowderBlue |
|||
| |
| group1 = [[Quinolone antibiotic#Second generation|2nd generation]] |
||
| list1 = |
|||
| list2 = |
|||
* [[Ciprofloxacin]]<sup>#</sup> |
* [[Ciprofloxacin]]<sup>#</sup> |
||
* [[Ofloxacin]] |
|||
* [[Enoxacin]]<sup>‡</sup> |
* [[Enoxacin]]<sup>‡</sup> |
||
* [[Fleroxacin]]<sup>‡</sup> |
* [[Fleroxacin]]<sup>‡</sup> |
||
* [[Lomefloxacin]] |
* [[Lomefloxacin]]<sup>‡</sup> |
||
* [[Nadifloxacin]] |
* [[Nadifloxacin]]<sup>‡</sup>/[[Levonadifloxacin]]/[[Alalevonadifloxacin]] |
||
* [[Norfloxacin]]<sup>‡</sup> |
|||
* [[Ofloxacin]] |
|||
* [[Pefloxacin]]<sup>‡</sup> |
|||
* [[Norfloxacin]] |
|||
* [[Rufloxacin]]<sup>‡</sup> |
|||
* [[Pefloxacin]] |
|||
* [[Rufloxacin]] |
|||
| |
| group2 = [[Quinolone antibiotic#Third generation|3rd generation]] |
||
| list2 = |
|||
| list3 = |
|||
* [[Levofloxacin]]<sup>#</sup> |
|||
* [[Balofloxacin]] |
|||
* [[Balofloxacin]]<sup>‡</sup> |
|||
* [[Grepafloxacin]]<sup>‡</sup> |
* [[Grepafloxacin]]<sup>‡</sup> |
||
* [[Pazufloxacin]]<sup>‡</sup> |
|||
* [[Levofloxacin]] |
|||
* [[Pazufloxacin]] |
|||
* [[Sparfloxacin]]<sup>‡</sup> |
* [[Sparfloxacin]]<sup>‡</sup> |
||
* [[Temafloxacin]]<sup>‡</sup> |
* [[Temafloxacin]]<sup>‡</sup> |
||
* [[Tosufloxacin]] |
* [[Tosufloxacin]]<sup>‡</sup> |
||
| |
| group3 = [[Quinolone antibiotic#Fourth generation|4th generation]] |
||
| list3 = |
|||
| list4 = |
|||
* [[Besifloxacin]] |
* [[Besifloxacin]] |
||
* [[Delafloxacin]] |
|||
* [[Gatifloxacin]] |
|||
* [[Finafloxacin]] |
|||
* [[Gemifloxacin]] |
|||
* [[Moxifloxacin]]<sup>#</sup> |
|||
* [[Clinafloxacin]]<sup>†</sup> |
* [[Clinafloxacin]]<sup>†</sup> |
||
* [[Garenoxacin]] |
* [[Garenoxacin]]<sup>‡</sup> |
||
* [[Prulifloxacin]]<sup>‡</sup> |
|||
* [[Gemifloxacin]] |
|||
* [[Sitafloxacin]]<sup>‡</sup> |
|||
* [[Moxifloxacin]] |
|||
* [[Gatifloxacin]]<sup>‡</sup> |
|||
* [[Sitafloxacin]] |
|||
* [[Trovafloxacin]]<sup>‡</sup>/[[Alatrofloxacin]]<sup>‡</sup> |
* [[Trovafloxacin]]<sup>‡</sup>/[[Alatrofloxacin]]<sup>‡</sup> |
||
* [[Prulifloxacin]] |
|||
| group5 = [[Fluoroquinolone#Veterinary_use|Vet.]] |
|||
| group4 = [[Quinolone antibiotic#Veterinary use|Veterinary]] |
|||
| list5 = |
|||
| list4 = |
|||
* [[Danofloxacin]] |
* [[Danofloxacin]] |
||
* [[Difloxacin]] |
* [[Difloxacin]] |
||
| Line 128: | Line 144: | ||
* [[Orbifloxacin]] |
* [[Orbifloxacin]] |
||
* [[Pradofloxacin]] |
* [[Pradofloxacin]] |
||
* [[Sarafloxacin]] |
* [[Sarafloxacin]]<sup>‡</sup> |
||
}} |
|||
| group3 = Newer non-fluorinated |
|||
| group6 = Related ([[DNA gyrase|DG]]) |
|||
| list3 = |
|||
* [[Nemonoxacin]] |
|||
* [[Ozenoxacin]] |
|||
| group4 = Related ([[DNA gyrase|DG]]) |
|||
| list4 = |
|||
* [[Aminocoumarin]]s: [[Novobiocin]] |
* [[Aminocoumarin]]s: [[Novobiocin]] |
||
}} |
}} |
||
| group3 = [[Anaerobic organism|Anaerobic]] DNA<br />[[Nucleic acid inhibitor#DNA inhibitors|inhibitors]] |
|||
}} |
|||
| list3 = {{Navbox|child |
|||
| group1 = [[Nitroimidazole]] derivatives |
|||
| group3 = [[Anaerobic organism|Anaerobic]] DNA<br />[[Nucleic_acid_inhibitor#DNA_inhibitors|inhibitors]] |
|||
| list1 = |
|||
| list3 = {{Navbox|child |
|||
* [[Metronidazole]]<sup>#</sup> |
|||
| groupstyle = background-color: PowderBlue |
|||
* [[Ornidazole]] |
|||
* [[Secnidazole]] |
|||
| group1 = [[Nitroimidazole|Nitro-]] [[imidazole]] derivatives |
|||
| list1 = |
|||
* [[Metronidazole]]<sup>#</sup> |
|||
* [[Tinidazole]] |
* [[Tinidazole]] |
||
* [[Ornidazole]] |
|||
| group2 = [[Nitrofuran]] derivatives |
| group2 = [[Nitrofuran]] derivatives |
||
| list2 |
| list2 = |
||
* [[ |
* [[Furazolidone]]<sup>‡</sup> |
||
* [[Nifuroxazide]] |
|||
* [[Furazolidone]]<sup>‡</sup> |
|||
* [[Nifurtoinol]] |
* [[Nifurtoinol]] |
||
* [[Nifurzide]] |
|||
* [[Nitrofurantoin]]<sup>#</sup> |
|||
* [[Nitrofurazone]] |
|||
}} |
|||
| group4 = [[RNA]] synthesis |
|||
}} |
|||
| list4 = {{Navbox|child |
|||
| group1 = [[Rifamycin]]s/<br />[[RNA-dependent RNA polymerase|RNA polymerase]] |
|||
| group4 = [[RNA]] synthesis |
|||
| list1 = |
|||
| list4 = {{Navbox|child |
|||
| groupstyle = background-color: PowderBlue |
|||
| group1 = [[Rifamycin]]s/<br/>[[RNA-dependent RNA polymerase|RNA polymerase]] |
|||
| list1 = |
|||
* [[Rifampicin]]<sup>#</sup> |
* [[Rifampicin]]<sup>#</sup> |
||
* [[Rifabutin]] |
* [[Rifabutin]]<sup>#</sup> |
||
* [[Rifapentine]] |
* [[Rifapentine]]<sup>#</sup> |
||
* [[Rifaximin]] |
* [[Rifaximin]] |
||
* [[Rifalazil]]<sup>§</sup> |
|||
| group2 = [[Lipiarmycin]]s |
|||
| list2 = |
|||
* [[Fidaxomicin]] |
|||
}} |
}} |
||
| belowstyle = background: transparent; padding: 0px; |
|||
| belowstyle = background: transparent; padding: 0px; |
|||
| below = {{PharmNavFootnote}}{{Bacteria navs}} |
|||
| below = {{PharmNavFootnote}} |
|||
}}<noinclude> |
}}<noinclude> |
||
{{collapsible option}} |
|||
[[Category:Nucleic acid inhibitor antibiotics]] |
|||
[[Category: |
[[Category:Drug templates by ATC]] |
||
[[Category:Bactericides|*]] |
|||
[[sr:Шаблони:Antibiotici inhibitori nukleinskih kiselina-lat]] |
|||
[[zh:Template: |
|||
</noinclude> |
</noinclude> |
||
Latest revision as of 17:15, 4 May 2024
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Nucleic acid inhibitors|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Nucleic acid inhibitors|state=expanded}}will show the template expanded, i.e. fully visible.